Millennium Management
TXG icon

Millennium Management’s 10x Genomics TXG Stock Holding History

Millennium Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.48M Sell
116,833
-1,951,581
-94% -$51.1M ﹤0.01% 3095
2026
Q1 		$43.9M Buy
2,068,414
+826,048
+66% +$16.5M 0.02% 918
2025
Q4 		$20.3M Sell
1,242,366
-4,195,603
-77% -$63.4M 0.01% 1563
2025
Q3 		$63.6M Buy
5,437,969
+2,554,142
+89% +$33.3M 0.03% 703
2025
Q2 		$33.4M Sell
2,883,827
-2,493,665
-46% -$22.7M 0.02% 1102
2025
Q1 		$46.9M Buy
5,377,492
+4,386,327
+443% +$55.3M 0.03% 814
2024
Q4 		$14.2M Buy
991,165
+72,408
+8% +$1.14M 0.01% 1821
2024
Q3 		$20.7M Sell
918,757
-441,994
-32% -$9.14M 0.01% 1521
2024
Q2 		$26.5M Buy
1,360,751
+228,323
+20% +$5.98M 0.01% 1263
2024
Q1 		$42.5M Buy
1,132,428
+857,293
+312% +$37.7M 0.02% 936
2023
Q4 		$15.4M Buy
275,135
+39,573
+17% +$1.72M 0.01% 1783
2023
Q3 		$9.72M Buy
235,562
+147,008
+166% +$7.65M ﹤0.01% 2082
2023
Q2 		$4.94M Sell
88,554
-135,427
-60% -$7.33M ﹤0.01% 2682
2023
Q1 		$12.5M Sell
223,981
-989,413
-82% -$46.2M 0.01% 1739
2022
Q4 		$44.2M Buy
1,213,394
+999,487
+467% +$32.7M 0.02% 830
2022
Q3 		$6.09M Buy
213,907
+146,891
+219% +$5.6M ﹤0.01% 2702
2022
Q2 		$3.03M Sell
67,016
-127,300
-66% -$6.6M ﹤0.01% 3290
2022
Q1 		$14.8M Buy
194,316
+125,914
+184% +$11M 0.01% 1700
2021
Q4 		$10.2M Buy
+68,402
New +$10.5M 0.01% 2129
2021
Q2 		– Sell
-156,873
Closed -$28.4M – 7124
2021
Q1 		$28.4M Sell
156,873
-182,590
-54% -$31.5M 0.02% 830
2020
Q4 		$48.1M Buy
339,463
+285,238
+526% +$41.4M 0.03% 478
2020
Q3 		$6.76M Buy
+54,225
New +$5.69M 0.01% 1566
2020
Q2 		– Sell
-90,888
Closed -$5.66M – 4607
2020
Q1 		$5.66M Buy
90,888
+65,802
+262% +$5.14M 0.01% 1243
2019
Q4 		$1.91M Sell
25,086
-23,420
-48% -$1.41M ﹤0.01% 2648
2019
Q3 		$2.44M Buy
+48,506
New +$2.68M ﹤0.01% 2326

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management's TXG Position: Q2 2026 in Review

Millennium Management reduced its 10x Genomics (TXG) stake by 94% in Q2 2026, selling an estimated $51.1M and leaving 116,833 shares worth $4.48M. The position accounts for ﹤0.01% of the portfolio, ranked #3095.

Millennium Management first reported a position in TXG in Q3 2019 and has held it in 25 quarters since. The position peaked at $63.6M in Q3 2025. 391 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Millennium Management held 116,833 shares of 10x Genomics worth $4.48M as of Q2 2026.
  • Millennium Management sold 1,951,581 10x Genomics shares in Q2 2026, an estimated $51.1M.
  • 10x Genomics made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #3095 holding.
  • Millennium Management first reported a position in 10x Genomics in Q3 2019 and has held it in 25 quarters since.
  • Millennium Management's 10x Genomics position peaked at $63.6M in Q3 2025.
  • 391 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.